Macquarie Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $50.5M | Buy |
|
|||||
|
2025
Q1 | $57.6M | Buy |
|
|||||
|
2024
Q4 | $63.6M | Sell |
|
|||||
|
2024
Q3 | $67.3M | Buy |
|
|||||
|
2024
Q2 | $62M | Buy |
|
|||||
|
2024
Q1 | $66.4M | Buy |
|
|||||
|
2023
Q4 | $81.6M | Buy |
|
|||||
|
2023
Q3 | $75M | Buy |
|
|||||
|
2023
Q2 | $97.1M | Sell |
|
|||||
|
2023
Q1 | $79.2M | Buy |
|
|||||
|
2022
Q4 | $66M | Buy |
|
|||||
|
2022
Q3 | $58.9M | Buy |
|
|||||
|
2022
Q2 | $69M | Buy |
|
|||||
|
2022
Q1 | $105K | Sell |
|
|||||
|
2021
Q4 | $108M | Sell |
|
|||||
|
2021
Q3 | $102M | Buy |
|
|||||
|
2021
Q2 | $106M | Buy |
|
|||||
|
2021
Q1 | $95.9M | Sell |
|
|||||
|
2020
Q4 | $86.9M | Buy |
|
|||||
|
2020
Q3 | $59M | Buy |
|
|||||
|
2020
Q2 | $53.3M | Sell |
|
|||||
|
2020
Q1 | $42.7M | Sell |
|
|||||
|
2019
Q4 | $83.5M | Buy |
|
|||||
|
2019
Q3 | $69.2M | Sell |
|
|||||
|
2019
Q2 | $67.9M | Sell |
|
|||||
|
2019
Q1 | $66.8M | Sell |
|
|||||
|
2018
Q4 | $51.8M | Buy |
|
|||||
|
2018
Q3 | $62.6M | Buy |
|
|||||
|
2018
Q2 | $57.1M | Sell |
|
|||||
|
2018
Q1 | $50.4M | Buy |
|
|||||
|
2017
Q4 | $38.5M | Buy |
|
|||||
|
2017
Q3 | $38.4M | Buy |
|
|||||
|
2017
Q2 | $32.7M | Sell |
|
|||||
|
2017
Q1 | $30M | Buy |
|
|||||
|
2016
Q4 | $25.8M | Buy |
|
|||||
|
2016
Q3 | $22.6M | Sell |
|
|||||
|
2016
Q2 | $51.2M | Buy |
|
|||||
|
2016
Q1 | $18.3M | Buy |
|
|||||
|
2015
Q4 | $16.2M | Buy |
|
|||||
|
2015
Q3 | $16.2M | Buy |
|
|||||
|
2015
Q2 | $16.3M | Sell |
|
|||||
|
2015
Q1 | $15.3M | Buy |
|
|||||
|
2014
Q4 | $9.38M | Buy |
|
|||||
|
2014
Q3 | $5.9M | Buy |
|
|||||
|
2014
Q2 | $5.52M | Buy |
|
|||||
|
2014
Q1 | $4.8M | Buy |
|
|||||
|
2013
Q4 | $3.46M | Buy |
|
|||||
|
2013
Q3 | $2.51M | Sell |
|
|||||
|
2013
Q2 | $2.39M | Buy |
|